Vaccinations

China to test nasal spray coronavirus vaccine

Some scientists believe that nasal sprays can be more effective than injections.

12/09/2020
Israel to hold human trials on COVID-19 vaccine with 100 volunteers

The report came following an announcement in June by the IIBR on the success of the vaccine in trials on hamsters.

11/09/2020
Jewish Law - Preparing for flu season and a coronavirus vaccine

Vaccinations are undoubtedly one of the greater inventions of the modern era – and this blessing sometimes leads to complacency.

By SHLOMO BRODY
29/07/2020
Moderna vaccine protects against COVID-19 in monkey study

It appeared to be an improvement over results of AstraZeneca's COVID-19 vaccine in a similar study.

By REUTERS
29/07/2020
Dr. Daniel Shepshelovich
FDA-approved vaccines ‘remarkably safe’ new study finds

“Vaccines are one of the great achievements of modern medicine."

Two babies hospitalized with rare meningitis after parents refuse vaccine

"What we went through was hell, one of the worst things I went through in my life: to know that my daughter was in danger of dying," the father of one of the babies told Channel 12.

Bottles labeled "Vaccine" stand near medical syringe in front of "Coronavirus COVID-19" display
Israel looking to acquire COVID-19 vaccines from AstraZeneca

The vaccine stands out because recent results show that it's effective with treating healthy patients and offers "double layered," long-term protection against the virus.

Bottles labeled "Vaccine" stand near medical syringe in front of "Coronavirus COVID-19" display
COVID-19 vaccine program to start production by late summer - US official

The US government has given grants ranging from several hundred million dollars to over $1 billion to Johnson & Johnson, Moderna Inc, AstraZeneca Plc and Novovax Inc.

By REUTERS
14/07/2020
Gates: COVID-19 meds should to go to those in need, not 'highest bidder'

"We need leaders to make these hard decisions about distributing based on equity, not just on market-driven factors."

By REUTERS
11/07/2020
Gilead says additional data on remdesivir shows improved clinical recovery

Findings from the analysis of its late-stage study showed that 74.4% of remdesivir-treated patients recovered by Day 14 versus 59.0% of patients receiving standard of care, the company said.

By REUTERS
10/07/2020
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use